# Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/addition-of-rituximab-to-fludarabine-and-cyclophosphamide-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael Hallek,Kirsten Fischer,Guenter Fingerle-Rowson,AM Fink,R. Busch,Jiřı́ Mayer,M. Hensel,Georg Hopfinger,G Hess,Ulrich von Grünhagen,Michèle Bergmann,J. Catalano,Pier Luigi Zinzani,Federico Caligaris‐Cappio,JF Seymour,A Berrébi,Ulrich Jäger,Bruno Cazin,Marek Trněný,Anne Westermann,C-M Wendtner,BF Eichhorst,Peter Staib,Andreas Bühler,Dirk Winkler,Thorsten Zenz,Sebastian Böttcher,Matthias Ritgen,Myriam Mendila,Michael Kneba,Hartmut Döhner,S. Stilgenbauer |
| Citations | 1,874 |
| DOI | 10.1016/s0140-6736(10)61381-5 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2140606816 |
| PMID | 20888994 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Dirk Winkler](https://scholariq.org/researchers/dirk-winkler/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Paper topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.